Cosciens Biopharma Stock Today
| CSCI Stock | 4.28 0.25 6.20% |
Performance0 of 100
| Odds Of DistressOver 63
|
COSCIENS Biopharma is selling at 4.28 as of the 20th of January 2025; that is 6.20% up since the beginning of the trading day. The stock's open price was 4.03. COSCIENS Biopharma has more than 63 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 20th of January 2025. Click here to learn more.
Category Healthcare |
COSCIENS Biopharma is entity of Canada. It is traded as Stock on TO exchange. The company has 3.12 M outstanding shares of which 786 shares are currently shorted by private and institutional investors with about 0.51 days to cover all short positions. More on COSCIENS Biopharma
Moving together with COSCIENS Stock
Moving against COSCIENS Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
COSCIENS Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. COSCIENS Biopharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding COSCIENS Biopharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | ICDD MBA |
| Business Concentration | Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) |
COSCIENS Biopharma (CSCI) is traded on Toronto Exchange in Canada and employs 5 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate COSCIENS Biopharma's market, we take the total number of its shares issued and multiply it by COSCIENS Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. COSCIENS Biopharma operates under Healthcare sector and is part of Biotechnology industry. The entity has 3.12 M outstanding shares of which 786 shares are currently shorted by private and institutional investors with about 0.51 days to cover all short positions.
COSCIENS Biopharma generates negative cash flow from operations
Check COSCIENS Biopharma Probability Of Bankruptcy
Ownership AllocationThe market capitalization of COSCIENS Biopharma is USD13.18 Million. Almost 92.35 percent of COSCIENS Biopharma outstanding shares are held by general public with 1.29 (percent) owned by insiders and only 6.36 % by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check COSCIENS Ownership Details
COSCIENS Biopharma Risk Profiles
Although COSCIENS Biopharma's alpha and beta are two of the key measurements used to evaluate COSCIENS Biopharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.02 | |||
| Standard Deviation | 4.95 | |||
| Variance | 24.55 | |||
| Risk Adjusted Performance | (0.02) |
COSCIENS Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in COSCIENS Biopharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
COSCIENS Biopharma Corporate Executives
Elected by the shareholders, the COSCIENS Biopharma's board of directors comprises two types of representatives: COSCIENS Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of COSCIENS. The board's role is to monitor COSCIENS Biopharma's management team and ensure that shareholders' interests are well served. COSCIENS Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, COSCIENS Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Giuliano Fratta | Senior CFO | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in COSCIENS Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in COSCIENS Stock, please use our How to Invest in COSCIENS Biopharma guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.